Abstract
In terms of treating diseases, minimally invasive treatment has become a key element in reducing perioperative complications. Among the various minimally invasive treatments, cryotherapy is often used in urology to treat various types of cancers, especially prostate cancer and renal cancer. In prostate cancer, the increased incidence of low-risk, localized prostate cancer has made minimally invasive treatment modalities an attractive option. Focal cryotherapy for localized unilateral disease offers the added benefit of minimal morbidities. In renal cancer, owing to the increasing utilization of cross-sectional imaging, nearly 70% of newly detected renal masses are stage T1a, making them more susceptible to minimally invasive nephron-sparing therapies including laparoscopic and robotic partial nephrectomy and ablative therapies. This article reviews the various outcomes of cryotherapy compared with other treatments and the possible uses of cryotherapy in surgery.
| Original language | English |
|---|---|
| Pages (from-to) | 780-788 |
| Number of pages | 9 |
| Journal | Korean Journal of Urology |
| Volume | 55 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2014 Jan 1 |
Fingerprint
Keywords
- Cryotherapy
- Kidney
- Neoplasm
- Prostate
ASJC Scopus subject areas
- Urology
Cite this
Current status of cryotherapy for prostate and kidney cancer. / Cho, Seok; Kang, Seok Ho.
In: Korean Journal of Urology, Vol. 55, No. 12, 01.01.2014, p. 780-788.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Current status of cryotherapy for prostate and kidney cancer
AU - Cho, Seok
AU - Kang, Seok Ho
PY - 2014/1/1
Y1 - 2014/1/1
N2 - In terms of treating diseases, minimally invasive treatment has become a key element in reducing perioperative complications. Among the various minimally invasive treatments, cryotherapy is often used in urology to treat various types of cancers, especially prostate cancer and renal cancer. In prostate cancer, the increased incidence of low-risk, localized prostate cancer has made minimally invasive treatment modalities an attractive option. Focal cryotherapy for localized unilateral disease offers the added benefit of minimal morbidities. In renal cancer, owing to the increasing utilization of cross-sectional imaging, nearly 70% of newly detected renal masses are stage T1a, making them more susceptible to minimally invasive nephron-sparing therapies including laparoscopic and robotic partial nephrectomy and ablative therapies. This article reviews the various outcomes of cryotherapy compared with other treatments and the possible uses of cryotherapy in surgery.
AB - In terms of treating diseases, minimally invasive treatment has become a key element in reducing perioperative complications. Among the various minimally invasive treatments, cryotherapy is often used in urology to treat various types of cancers, especially prostate cancer and renal cancer. In prostate cancer, the increased incidence of low-risk, localized prostate cancer has made minimally invasive treatment modalities an attractive option. Focal cryotherapy for localized unilateral disease offers the added benefit of minimal morbidities. In renal cancer, owing to the increasing utilization of cross-sectional imaging, nearly 70% of newly detected renal masses are stage T1a, making them more susceptible to minimally invasive nephron-sparing therapies including laparoscopic and robotic partial nephrectomy and ablative therapies. This article reviews the various outcomes of cryotherapy compared with other treatments and the possible uses of cryotherapy in surgery.
KW - Cryotherapy
KW - Kidney
KW - Neoplasm
KW - Prostate
UR - http://www.scopus.com/inward/record.url?scp=84916607962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84916607962&partnerID=8YFLogxK
U2 - 10.4111/kju.2014.55.12.780
DO - 10.4111/kju.2014.55.12.780
M3 - Review article
C2 - 25512811
AN - SCOPUS:84916607962
VL - 55
SP - 780
EP - 788
JO - Korean Journal of Urology
JF - Korean Journal of Urology
SN - 2005-6737
IS - 12
ER -